1. Articles in category: Funding

    1-24 of 24
    1. New research points to potential targeted treatments of neuroblastoma tumours

      New research points to potential targeted treatments of neuroblastoma tumours

      Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research by the University of Chicago Medicine.

      The findings lay the groundwork for developing more targeted treatments for...

      Read Full Article
      Mentions: MYCN
    2. Potential for more targeted treatments of neuroblastoma tumors

      Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research. The findings lay the groundwork for developing more targeted treatments for particularly deadly variations of the cancer.

      Read Full Article
      Mentions: MYCN
    3. New research points to potential for more targeted treatments of neuroblastoma tumors

      New research points to potential for more targeted treatments of neuroblastoma tumors

      ( University of Chicago Medical Center ) Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research by the University of Chicago Medicine. The findings lay the groundwork for developing more targeted treatments for particularly deadly variations of the cancer.

      Read Full Article
      Mentions: MYCN
    4. ICR scientists awarded £1.5m precision medicine funding for targeted, less toxic childhood cancer treatments

      ICR scientists awarded £1.5m precision medicine funding for targeted, less toxic childhood cancer treatments

      Scientists from The Institute of Cancer Research, London, have been awarded £1.5 million by the charity Children with Cancer UK to advance precision medicine in the UK and improve cancer treatment for children and young adults.

      Read Full Article
      Mentions: Treatment
    5. St. Baldrick's Foundation Announces the Childhood Cancer STAR Act was Approved by the House and Now Moves to the Senate

      St. Baldrick's Foundation Announces the Childhood Cancer STAR Act was Approved by the House and Now Moves to the Senate

      "The St. Baldrick's Foundation, the largest private funder of childhood cancer research grants, is excited to announce that the Childhood Cancer STAR (Survivorship, Treatment, Access and Research) Act has passed the House of Representatives and is now moving on to the Senate. The Childhood Cancer STAR Act is an important bipartisan legislation designed to advance pediatric cancer research and child-focused cancer treatments, while also improving childhood cancer surveillance, and providing enhanced resources for survivors and those impacted by kids' cancers."

      Read Full Article
      Mentions: Treatment
    6. Stand Up To Cancer Launches "Catalyst," a New Research Program Supported by Industry

      "Under the SU2C Catalyst program, companies like Merck, Bristol-Myers Squibb and Genentech will donate funds to support collaborative research studies using products the companies will provide, such as new pharmaceutical compounds that they are developing or approved agents that can be investigated for other uses.  

      Through its scientific partner, the American Association for Cancer Research (AACR), SU2C will issue a Request for Proposals (RFP) to the scientific community based on each company's commitment of funding and materials such as drugs and diagnostic tests. The RFP will lay out the compounds that will be available, the research emphasis, the estimated ...

      Read Full Article
    7. Input-outcome disparities in biomedical research [Medical Sciences]

      "We consider several possibilities for the growing input-outcome disparity including the prior elimination of easier research questions, increasing specialization, overreliance on reductionism, a disproportionate emphasis on scientific outputs, and other negative pressures on the scientific enterprise. Monitoring the efficiency of research investments in producing positive societal outcomes may be a useful mechanism for weighing the efficacy of reforms to the scientific enterprise. Understanding the causes of the increasing input-outcome disparity in biomedical research may improve society’s confidence in science and provide support for growing future research investments."

      Read Full Article
    8. Cancer Research UK launches scheme to bring together engineers, physicists and biologists

      "A new funding scheme launched by Cancer Research UK today (Thursday) looks to bring new insight to some of cancer’s biggest challenges.  The Cancer Research UK Multidisciplinary Project Award will fund projects that encourage collaborations between cancer researchers and scientists from the engineering and physical sciences."

      Read Full Article
    9. Children's Cancer and Leukaemia Group (CCLG)

      CCLG is pleased to be funding three new novel research studies into childhood cancer. The studies all make use of samples from the CCLG Tissue Bank, a vital resource for childhood cancer researchers which ensures that sufficient tissue samples of these rare diseases are available to conduct meaningful research. The aim of the pilot grants is to enable researchers to obtain preliminary data that will lead onto more extensive research projects.

      Read Full Article
      Mentions: Pre-Clinical
    10. Calgary study to examine childhood cancer survivors

      Calgary study to examine childhood cancer survivors

        By Eva Ferguson, Calgary Herald June 26, 2014  Tweet Pin It Comment 0  * Story * Photos ( 1 )   Samantha Andres, who was diagnosed with childhood cancer at 8 years old, is pictured in Calgary. Photograph by: Leah Hennel Leah Hennel , Calgary Herald Samantha Andres was eight when she was struck in the leg by a ball that she was tossing back and forth with her brother. It hit a bump on her leg that she’d noticed sometime ago and thought nothing of.

      Read Full Article
    11. Thirty percent cuts to children’s cancer research? Unacceptable

      Just weeks before she died of a brain tumor, ten-year-old Gabriella Miller put it best. When asked what message she would give to the nation’s political leaders about the need for children’s cancer research, she responded in a YouTube video that went viral: “Talk is bull___! We need action.”
       
      Cancer kills more children in the U.S. than any other disease -- more than AIDS, asthma, diabetes, cystic fibrosis and congenital anomalies combined. Yet government funding for pediatric cancer research through the National Cancer Institute (NCI) has declined by 30 percent over the last decade, with further significant cuts ...

      Read Full Article
    12. A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow

      Protocol
      09-161

      Full Title
      3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow: A Phase II Study

      Phase
      II

      Purpose

      Neuroblastoma is a solid tumor that mainly affects young persons and can be very difficult to treat successfully. Although a combination of chemotherapy, radiation therapy, and surgery can help patients with advanced disease achieve remission, many patients experience a relapse of their disease.

      Read Full Article
    13. Weekly Roundup 03/24 …

      New research suggests that treating patients with non-steroidal anti-inflammatory drugs (NSAIDs) may mobilise more stem cells out of the bone marrow for peripheral blood stem cell collection – in animal studies by as much as four to six times.

      Peter Adamson, MD, head of the Children’s Oncology Group, expresses his fears regarding what the sequestration will mean for future funding of paediatric clinical trials by the National Cancer Institute.

      Read Full Article
    14. Neuroblastoma Parent Conference July 29-30

      During the past decade, CNCF has succeeded in bringing an ambitious idea to life. Inviting NB experts to Chicago to speak, providing lodging, meals, some travel funds, and activities for children for NB families who could not otherwise afford to attend such a meeting is a remarkable accomplishment. No other foundation has attempted to duplicate this effort for any other rare disease to our knowledge.

      Read Full Article
    15. Dr Giselle Sholler accepts new position at Van Andel Research Institute

      Dr Sholler completed medical school at New York Medical College, in Valhalla, NY. She was a resident in pediatrics and a fellow in pediatric hematology/oncology at Brown University before moving to the University of Vermont in 2005. Her research focuses on new therapies for neuroblastoma and medulloblastoma.

      She describes her transition to new her position at Van Andel Research Institute (VARI) in an interview at AACR:

      Read Full Article
      Mentions: NMTRC
    1-24 of 24
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles